{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:17:27Z","timestamp":1789535847871,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jsbmb.2019.105490","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T11:27:44Z","timestamp":1570102064000},"page":"105490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The impact of steroids on the injured podocytes in nephrotic syndrome"],"prefix":"10.1016","volume":"196","author":[{"given":"Seyed Mahdi","family":"Hosseiniyan Khatibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Ardalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Abediazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Zununi Vahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.jsbmb.2019.105490_bib0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000481634","article-title":"Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis","volume":"47","author":"Campbell","year":"2018","journal-title":"Am. J. Nephrol."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pharmthera.2011.12.004","article-title":"Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor","volume":"134","author":"Clark","year":"2012","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/pgs-2017-0084","article-title":"NR3C1 gene polymorphisms are associated with steroid resistance in patients with primary nephrotic syndrome","volume":"19","author":"Liu","year":"2018","journal-title":"Pharmacogenomics"},{"issue":"14","key":"10.1016\/j.jsbmb.2019.105490_bib0020","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2217\/pgs.15.101","article-title":"Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome","volume":"16","author":"Cuzzoni","year":"2015","journal-title":"Pharmacogenomics"},{"issue":"5","key":"10.1016\/j.jsbmb.2019.105490_bib0025","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2215\/CJN.12991117","article-title":"Glucocorticoids in the treatment of glomerular diseases: pitfalls and pearls","volume":"13","author":"Ponticelli","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.jsbmb.2019.105490_bib0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00467-015-3116-4","article-title":"Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?","volume":"31","author":"Muller-Deile","year":"2016","journal-title":"Pediatr. Nephrol."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0035","doi-asserted-by":"crossref","first-page":"F46","DOI":"10.1152\/ajprenal.00184.2016","article-title":"The podocyte as a direct target for treatment of glomerular disease?","volume":"311","author":"Mallipattu","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"5","key":"10.1016\/j.jsbmb.2019.105490_bib0040","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1074\/jbc.M116.755546","article-title":"Alpha actinin 4 (ACTN4) Regulates Glucocorticoid Receptor-mediated Transactivation and transrepression in podocytes","volume":"292","author":"Zhao","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.jsbmb.2019.105490_bib0045","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ki.2010.62","article-title":"Glucocorticoids protect renal mesangial cells from apoptosis by increasing cellular sphingosine-1-phosphate","volume":"77","author":"Forster","year":"2010","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.jsbmb.2019.105490_bib0050","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.ki.5001655","article-title":"Direct effects of dexamethasone on human podocytes","volume":"70","author":"Xing","year":"2006","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.jsbmb.2019.105490_bib0055","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1128\/MCB.01474-12","article-title":"The glucocorticoid receptor and KLF15 regulate gene expression dynamics and integrate signals through feed-forward circuitry","volume":"33","author":"Sasse","year":"2013","journal-title":"Mol. Cell. Biol."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2019.105490_bib0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mce.2012.12.014","article-title":"How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering","volume":"380","author":"Ratman","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105490_bib0065","doi-asserted-by":"crossref","first-page":"101323","DOI":"10.11131\/2018\/101323","article-title":"The role of glucocorticoid receptors in podocytes and nephrotic syndrome","volume":"5","author":"Zhao","year":"2018","journal-title":"Nucl. Receptor Res."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105490_bib0070","doi-asserted-by":"crossref","first-page":"e60213","DOI":"10.1371\/journal.pone.0060213","article-title":"Microarray analyses of glucocorticoid and vitamin D3 target genes in differentiating cultured human podocytes","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105490_bib0075","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1152\/physrev.00058.2009","article-title":"Mammalian Kruppel-like factors in health and diseases","volume":"90","author":"McConnell","year":"2010","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105490_bib0080","doi-asserted-by":"crossref","first-page":"F259","DOI":"10.1152\/ajprenal.00550.2016","article-title":"The critical role of Kruppel-like factors in kidney disease","volume":"312","author":"Mallipattu","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105490_bib0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/labinvest.2010.170","article-title":"DNA binding-dependent glucocorticoid receptor activity promotes adipogenesis via Kruppel-like factor 15 gene expression","volume":"91","author":"Asada","year":"2011","journal-title":"Lab. Invest."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0090","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1681\/ASN.2015060672","article-title":"Kruppel-like factor 15 mediates glucocorticoid-induced restoration of podocyte differentiation markers","volume":"28","author":"Mallipattu","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.jsbmb.2019.105490_bib0095","first-page":"1593","article-title":"Loss of KLF15 accelerates chronic podocyte injury","volume":"42","author":"Han","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"23","key":"10.1016\/j.jsbmb.2019.105490_bib0100","doi-asserted-by":"crossref","first-page":"19122","DOI":"10.1074\/jbc.M112.345983","article-title":"Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation","volume":"287","author":"Mallipattu","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.jsbmb.2019.105490_bib0105","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1681\/ASN.2018030324","article-title":"Podocyte-specific induction of kruppel-like factor 15 restores differentiation markers and attenuates kidney injury in proteinuric kidney disease","volume":"29","author":"Guo","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","article-title":"Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome","volume":"17","author":"Clement","year":"2011","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.jsbmb.2019.105490_bib0115","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/labinvest.2014.163","article-title":"Serum amyloid A and inflammation in diabetic kidney disease and podocytes","volume":"95","author":"Anderberg","year":"2015","journal-title":"Lab. Invest."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1681\/ASN.2012111101","article-title":"Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids","volume":"25","author":"Wu","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0125","doi-asserted-by":"crossref","first-page":"9833","DOI":"10.1038\/s41598-017-10490-z","article-title":"Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jsbmb.2019.105490_bib0130","doi-asserted-by":"crossref","first-page":"35671","DOI":"10.1038\/srep35671","article-title":"RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ndt\/gfq617","article-title":"The podocyte as a direct target of immunosuppressive agents","volume":"26","author":"Schonenberger","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"10","key":"10.1016\/j.jsbmb.2019.105490_bib0140","doi-asserted-by":"crossref","first-page":"F1473","DOI":"10.1152\/ajprenal.00031.2012","article-title":"Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria","volume":"303","author":"Brahler","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"11","key":"10.1016\/j.jsbmb.2019.105490_bib0145","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00125-009-1493-6","article-title":"Podocytes produce homeostatic chemokine stromal cell-derived factor-1\/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes","volume":"52","author":"Sayyed","year":"2009","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105490_bib0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ki.1997.346","article-title":"Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides","volume":"52","author":"Niemir","year":"1997","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.jsbmb.2019.105490_bib0155","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.4049\/jimmunol.168.12.6244","article-title":"Expression of functional CCR and CXCR chemokine receptors in podocytes","volume":"168","author":"Huber","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jsbmb.2019.105490_bib0160","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fendo.2018.00302","article-title":"Nephrin Signaling in the podocyte: an updated view of signal regulation at the slit diaphragm and beyond","volume":"9","author":"Martin","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"6","key":"10.1016\/j.jsbmb.2019.105490_bib0165","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1007\/s11033-014-3222-6","article-title":"Role of nephrin phosphorylation inducted by dexamethasone and angiotensin II in podocytes","volume":"41","author":"Yu","year":"2014","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.jsbmb.2019.105490_bib0170","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/sj.ki.5001625","article-title":"Screening and identification of substances that regulate nephrin gene expression using engineered reporter podocytes","volume":"70","author":"Yamauchi","year":"2006","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.jsbmb.2019.105490_bib0175","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/sj.ki.5000317","article-title":"The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases","volume":"69","author":"Fujii","year":"2006","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.jsbmb.2019.105490_bib0180","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s10157-011-0479-0","article-title":"Dexamethasone increases the phosphorylation of nephrin in cultured podocytes","volume":"15","author":"Ohashi","year":"2011","journal-title":"Clin. Exp. Nephrol."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105490_bib0185","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1681\/ASN.2014121197","article-title":"Loss of epithelial membrane protein 2 aggravates podocyte injury via upregulation of Caveolin-1","volume":"27","author":"Wan","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.jsbmb.2019.105490_bib0190","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/ki.2008.19","article-title":"Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis","volume":"73","author":"Uchida","year":"2008","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105490_bib0195","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5483\/BMBRep.2013.46.4.270","article-title":"Nephrin phosphorylation regulates podocyte adhesion through the PINCH-1-ILK-alpha-parvin complex","volume":"46","author":"Zha","year":"2013","journal-title":"BMB Rep."},{"issue":"11","key":"10.1016\/j.jsbmb.2019.105490_bib0200","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ki.2010.64","article-title":"Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease","volume":"77","author":"Veron","year":"2010","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.jsbmb.2019.105490_bib0205","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1093\/ndt\/gfm403","article-title":"The nephrin-based slit diaphragm: new insight into the signalling platform identifies targets for therapy","volume":"22","author":"Aaltonen","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0210","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11427-010-0014-7","article-title":"Advanced oxidation protein products decrease expression of nephrin and podocin in podocytes via ROS-dependent activation of p38 MAPK","volume":"53","author":"Yang","year":"2010","journal-title":"Sci. China Life Sci."},{"issue":"5","key":"10.1016\/j.jsbmb.2019.105490_bib0215","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.3892\/mmr.2015.4370","article-title":"Prednisone inhibits the focal adhesion kinase\/receptor activator of NF-kappaB ligand\/mitogen-activated protein kinase signaling pathway in rats with adriamycin-induced nephropathy","volume":"12","author":"Ye","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"22","key":"10.1016\/j.jsbmb.2019.105490_bib0220","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0960-9822(01)00560-7","article-title":"WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin","volume":"11","author":"Palmer","year":"2001","journal-title":"Curr. Biol."},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105490_bib0225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.yexcr.2017.02.016","article-title":"Foxc1 and Foxc2 are necessary to maintain glomerular podocytes","volume":"352","author":"Motojima","year":"2017","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrneph.2011.151","article-title":"The podocyte cytoskeleton--key to a functioning glomerulus in health and disease","volume":"8","author":"Welsh","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"issue":"11","key":"10.1016\/j.jsbmb.2019.105490_bib0235","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/ki.2011.472","article-title":"Mechanisms of the proteinuria induced by Rho GTPases","volume":"81","author":"Wang","year":"2012","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.jsbmb.2019.105490_bib0240","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1681\/ASN.2016010060","article-title":"Investigations of glucocorticoid action in GN","volume":"28","author":"Kuppe","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0245","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1038\/s41598-017-06810-y","article-title":"Glucocorticoid therapy regulates podocyte motility by inhibition of Rac1","volume":"7","author":"McCaffrey","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jsbmb.2019.105490_bib0250","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1440-1797.2012.01645.x","article-title":"alpha-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury","volume":"17","author":"Liu","year":"2012","journal-title":"Nephrol. Carlton (Carlton)"},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2019.105490_bib0255","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11010-015-2528-6","article-title":"Dexamethasone-dependent modulation of cyclic GMP synthesis in podocytes","volume":"409","author":"Lewko","year":"2015","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0260","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/ndt\/gfq366","article-title":"Increased expression of olfactomedin-1 and myocilin in podocytes during puromycin aminonucleoside nephrosis","volume":"26","author":"Bohr","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0265","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ndt\/gfr271","article-title":"Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-kappaB-dependent pathway","volume":"27","author":"Shimada","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.jsbmb.2019.105490_bib0270","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1111\/j.1523-1755.2005.00723.x","article-title":"Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization","volume":"68","author":"Ransom","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsbmb.2019.105490_bib0275","first-page":"652059","article-title":"Dexamethasone resisted podocyte injury via stabilizing TRPC6 expression and distribution","volume":"2012","author":"Yu","year":"2012","journal-title":"Evid. Complement. Alternat. Med."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105490_bib0280","doi-asserted-by":"crossref","first-page":"F722","DOI":"10.1152\/ajprenal.00433.2005","article-title":"Podocyte proteoglycan synthesis is involved in the development of nephrotic syndrome","volume":"291","author":"Bjornson Granqvist","year":"2006","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"9","key":"10.1016\/j.jsbmb.2019.105490_bib0285","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1681\/ASN.2005020142","article-title":"Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins","volume":"16","author":"Wada","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0290","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1159\/000131892","article-title":"Dexamethasone\u2019s prosurvival benefits in podocytes require extracellular signal-regulated kinase phosphorylation","volume":"109","author":"Wada","year":"2008","journal-title":"Nephron. Exp. Nephrol."},{"issue":"6810","key":"10.1016\/j.jsbmb.2019.105490_bib0295","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2019.105490_bib0300","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.immunol.16.1.395","article-title":"BCL-2 family: regulators of cell death","volume":"16","author":"Chao","year":"1998","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.jsbmb.2019.105490_bib0305","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0955-0674(00)00216-7","article-title":"Regulation and function of the p53 tumor suppressor protein","volume":"13","author":"Ryan","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0310","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/exmp.2000.2345","article-title":"Puromycin aminonucleoside induces glomerular epithelial cell apoptosis","volume":"70","author":"Sanwal","year":"2001","journal-title":"Exp. Mol. Pathol."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0315","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9440(10)63966-1","article-title":"Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis","volume":"158","author":"Fornoni","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0320","doi-asserted-by":"crossref","first-page":"F173","DOI":"10.1152\/ajprenal.00240.2001","article-title":"Angiotensin II induces apoptosis in rat glomerular epithelial cells","volume":"283","author":"Ding","year":"2002","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"6","key":"10.1016\/j.jsbmb.2019.105490_bib0325","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI200112367","article-title":"Apoptosis in podocytes induced by TGF-beta and Smad7","volume":"108","author":"Schiffer","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105490_bib0330","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1523-1755.2004.00362.x","article-title":"Activation of a local tissue angiotensin system in podocytes by mechanical strain","volume":"65","author":"Durvasula","year":"2004","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105490_bib0335","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.transproceed.2012.07.160","article-title":"Role of bad in podocyte apoptosis induced by puromycin aminonucleoside","volume":"45","author":"Yu","year":"2013","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.jsbmb.2019.105490_bib0340","first-page":"326986","article-title":"Dexamethasone inhibits podocyte apoptosis by stabilizing the PI3K\/Akt signal pathway","volume":"2013","author":"Yu","year":"2013","journal-title":"Biomed Res. Int."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105490_bib0345","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1523-1755.2005.00205.x","article-title":"Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes","volume":"67","author":"Ransom","year":"2005","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.jsbmb.2019.105490_bib0350","doi-asserted-by":"crossref","first-page":"F1375","DOI":"10.1152\/ajprenal.00020.2013","article-title":"Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS","volume":"304","author":"Zhang","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105490_bib0355","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.3892\/mmr.2015.4226","article-title":"Inhibition of microRNA-30a prevents puromycin aminonucleoside-induced podocytic apoptosis by upregulating the glucocorticoid receptor alpha","volume":"12","author":"Xie","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.jsbmb.2019.105490_bib0360","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5935\/0101-2800.20130031","article-title":"Steroid-resistant idiopathic nephrotic syndrome in children: long-term follow-up and risk factors for end-stage renal disease","volume":"35","author":"Zagury","year":"2013","journal-title":"J. Bras. Nefrol."},{"issue":"9","key":"10.1016\/j.jsbmb.2019.105490_bib0365","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00467-010-1495-0","article-title":"Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations","volume":"25","author":"Benoit","year":"2010","journal-title":"Pediatr. Nephrol."},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105490_bib0370","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00467-017-3838-6","article-title":"Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?","volume":"34","author":"Preston","year":"2019","journal-title":"Pediatr. Nephrol."},{"issue":"12","key":"10.1016\/j.jsbmb.2019.105490_bib0375","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.ki.5002222","article-title":"The spectrum of podocytopathies: a unifying view of glomerular diseases","volume":"71","author":"Wiggins","year":"2007","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105490_bib0380","doi-asserted-by":"crossref","first-page":"F845","DOI":"10.1152\/ajprenal.00161.2010","article-title":"Dose- and time-dependent glucocorticoid receptor signaling in podocytes","volume":"299","author":"Guess","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105490_bib0385","doi-asserted-by":"crossref","first-page":"271","DOI":"10.15171\/jrip.2019.51","article-title":"The importance of genetic study in steroid-resistant nephrotic syndrome","volume":"8","author":"Zununi Vahed","year":"2019","journal-title":"J. Renal Inj. Prev."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076019302870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076019302870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:02:39Z","timestamp":1760745759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076019302870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":77,"alternative-id":["S0960076019302870"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105490","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of steroids on the injured podocytes in nephrotic syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105490"}}